Omixon
Omixon and GenDx have independently developed nanopore-based HLA typing kits that are currently for research use only but eventually aimed for diagnostic use.
Omixon Picks up Option to Acquire Organ Monitoring Group
The option comes as part of an alliance between the companies to codevelop an organ transplant monitoring assay.
Omixon Gets CE Mark for SeqOnce Bio Extraction-Free SARS-CoV-2 Detection Kit, Inks Licensing Deal
Under a licensing deal, Omixon will sell the AzureSeq-200 RT-PCR kit under its brand in Europe, the Middle East, and Africa.
Genomics England Awards £8M in Grants to Five Companies
The funding is part of a Small Business Research Initiative competition to promote the development of new technologies to advance the diagnostic application of genomic screening.
Omixon, Global Genomics Group Collaborate on HLA Genotyping Validation
NEW YORK (GenomeWeb) – Omixon today said it is collaborating with the Global Genomics Group to validate Omixon's Target HLA software to determine HLA genotypes from whole-genome sequencing datasets.
Jun 11, 2014
May 16, 2014
Aug 20, 2013
Paired Ends: Tim Hague
Premium
Jun 1, 2012
May 30, 2012
Feb 11, 2011
Feb 8, 2011